Dissimilar interaction of CB1/CB2 with lipid bilayers as revealed by molecular dynamics simulation

被引:6
|
作者
Ramos, Javier [1 ]
Cruz, Victor L. [1 ]
Martinez-Salazar, Javier [1 ]
Campillo, Nuria E. [2 ]
Paez, Juan A. [2 ]
机构
[1] CSIC, Inst Estruct Mat, GEMPPO, Dept Fis Macromol, Madrid 28006, Spain
[2] CSIC, Inst Quim Med, E-28006 Madrid, Spain
关键词
PROTEIN-COUPLED RECEPTOR; CANNABINOID CB1 RECEPTOR; PARTICLE MESH EWALD; DOCKING ANALYSIS; CELL BIOLOGY; ACTIVATION; HELIX; RAFTS; ENVIRONMENTS; MEMBRANES;
D O I
10.1039/c0cp01456g
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
Cannabinoid receptors CB1 and CB2 are a striking class of transmembrane proteins involved in a high number of important biological processes. In spite of the inherent similarity (40% in aminoacid sequence) these receptors are found in different cell environments. In addition to this, CB1 activity has been intimately associated with lipid rafts whereas CB2 has not. In this work we have performed a 50 nanosecond molecular dynamics simulation of the inactive conformations of both receptors inserted in a POPC lipid bilayer. Although in both cases the overall protein structure is maintained along the entire simulation we have found important differences in the protein-lipid interaction. While CB1 tends to distort the lipid bilayer regularity, especially in the extracellular moiety, CB2 has a minor influence on the lipid distribution along the plane of the bilayer. This observation is consistent with some experimental facts observed in these cannabinoid receptors with regard to lipid/protein interaction.
引用
收藏
页码:3660 / 3668
页数:9
相关论文
共 50 条
  • [1] Pharmacology of cannabinoid CB1 and CB2 receptors
    Pertwee, RG
    PHARMACOLOGY & THERAPEUTICS, 1997, 74 (02) : 129 - 180
  • [2] Cannabinoid CB1 and CB2 Receptor Signaling and Bias
    Ibsen, Mikkel Soes
    Connor, Mark
    Glass, Michelle
    CANNABIS AND CANNABINOID RESEARCH, 2017, 2 (01) : 48 - 60
  • [3] Anterior segment CB1 and CB2 cannabinoid receptors
    Song, ZH
    Jiang, J
    Hemesath, A
    McCloud, C
    Zhong, L
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2002, 43 : U1157 - U1157
  • [4] EXPRESSION OF CB1 AND CB2 IN HUMAN ATHEROSCLEROTIC PLAQUES
    Fazia, M. L.
    Di Francesco, A.
    De Cesare, D.
    Bucci, M.
    Ucchino, S.
    Spigonardo, F.
    Mezzetti, A.
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 5 - 5
  • [5] Virtual screening using docking and molecular dynamics of cannabinoid analogs against CB1 and CB2 receptors
    Aviz-Amador, Antistio
    Contreras-Puentes, Neyder
    Mercado-Camargo, Jairo
    Computational Biology and Chemistry, 2021, 95
  • [6] Virtual screening using docking and molecular dynamics of cannabinoid analogs against CB1 and CB2 receptors
    Aviz-Amador, Antistio
    Contreras-Puentes, Neyder
    Mercado-Camargo, Jairo
    COMPUTATIONAL BIOLOGY AND CHEMISTRY, 2021, 95
  • [7] Recent Development of CB2 Selective and Peripheral CB1/CB2 Cannabinoid Receptor Ligands
    Nevalainen, Tapio
    CURRENT MEDICINAL CHEMISTRY, 2014, 21 (02) : 187 - 203
  • [8] Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB1, CB2 and CB1/CB2 heteromer receptors
    Navarro, Gemma
    Varani, Katia
    Lillo, Alejandro
    Vincenzi, Fabrizio
    Rivas-Santisteban, Rafael
    Raich, Iu
    Reyes-Resina, Irene
    Ferreiro-Vera, Carlos
    Borea, Pier Andrea
    Sanchez de Medina, Veronica
    Nadal, Xavier
    Franco, Rafael
    PHARMACOLOGICAL RESEARCH, 2020, 159
  • [9] Imidazopyridine CB2 agonists: Optimization of CB2/CB1 selectivity and implications for in vivo analgesic efficacy
    Trotter, B. Wesley
    Nanda, Kausik K.
    Burgey, Christopher S.
    Potteiger, Craig M.
    Deng, James Z.
    Green, Ahren I.
    Hartnett, John C.
    Kett, Nathan R.
    Wu, Zhicai
    Henze, Darrell A.
    Della Penna, Kimberly
    Desai, Reshma
    Leitl, Michael D.
    Lemaire, Wei
    White, Rebecca B.
    Yeh, Suzie
    Urban, Mark O.
    Kane, Stefanie A.
    Hartman, George D.
    Bilodeau, Mark T.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (08) : 2354 - 2358
  • [10] Cannabigerol Action at Cannabinoid CB1 and CB2 Receptors and at CB1-CB2 Heteroreceptor Complexes
    Navarro, Gemma
    Varani, Katia
    Reyes-Resina, Irene
    Sanchez de Medina, Veronica
    Rivas-Santisteban, Rafael
    Sanchez-Carnerero Callado, Carolina
    Vincenzi, Fabrizio
    Casano, Salvatore
    Ferreiro-Vera, Carlos
    Canela, Enric, I
    Borea, Pier Andrea
    Nadals, Xavier
    Franco, Rafael
    FRONTIERS IN PHARMACOLOGY, 2018, 9